Market Research Report
Roadside Drug Testing Devices Market with COVID-19 Impact Analysis, By Modality, By Substance, By Sample Type, By End User, and By Region - Size, Share, & Forecast from 2021-2027
|Roadside Drug Testing Devices Market with COVID-19 Impact Analysis, By Modality, By Substance, By Sample Type, By End User, and By Region - Size, Share, & Forecast from 2021-2027|
Published: February 1, 2022
AnalystView Market Insights
Content info: 255 Pages
Delivery time: 2-3 business days
The global Roadside Drug Testing Devices market was valued at USD 980.4 million in 2020, growing with 4.6% CAGR during the forecast period, 2021-2027.
Roadside Drug Testing Devices are used to identify the existence of drug or their metabolites in a person's body through studying biological samples including hair, blood, & urine, etc.
The increasing road accidents due to the drink & drive scenario and increasingly becoming a matter of concern for government authorities across the globe are expected to drive the growth of the roadside drug testing devices market during the forecast period. For instance, according to the National Highway Traffic Safety Administration, every day around 28 people die in drunk & driving crashes in the US. Moreover, consistent with these cases healthcare industry will launch innovative products and are generating incremental opportunities for companies in the roadside drug testing devices market. For instance, Abbott Laboratories launched the SoToxa Mobile Test System in December 2019. This system is a novel roadside drug testing device and aimed to gain importance to combat drug-impaired driving and ensure road safety.
Based on region, the global Roadside Drug Testing Devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to hold the largest market share of the roadside drug testing devices market during the forecast period.
The growth in the region is attributed to the increase in late-night pubs and drinking bars for amusements contributing the drink-related accidents. For instance, according to the Centers for Disease Control and Prevention (CDC), around 4.7% of people aged 16 years or above in the U.S. are reported to be driving under the influence of marijuana and 0.9% are reported to be driving under the influence of illicit drugs other than marijuana. Besides, Europe will also contribute generously due to its rising rising student union clubs and night pubs. Additionally, growing preference amongst new generation youths to weekend club parties and adoption to western culture will also increase the market of roadside drug testing devices market.
The COVID-19 pandemic impacted various industries across the world over the previous couple of months. This can be attributed to substantial disruptions experienced through their respective production and supply-chain operations because of numerous precautionary lockdowns, in addition to other restrictions that had been enforced through governing authorities throughout the globe. The equal applies to the worldwide Roadside Drug Testing Devices market.
Moreover, consumer demand has additionally ultimately decreased as people at the moment are extra eager on getting rid of non-essential expenses from their respective budgets as the overall economic status of maximum individuals were seriously tormented by this outbreak. These aforementioned factors are anticipated to burden the sales trajectory of the worldwide Roadside Drug Testing Devices market over the forecast period. However, as respective governing authorities start to lift those enforced lockdowns, the global Roadside Drug Testing Devices market is anticipated to get better accordingly.
The key player adopted various strategies to sustain in the market such as merger & acquisition, consolidation, investment, partnership, product launch, and divestment. For instance, In October 2017, Abbott Laboratories acquired Alere, Inc. for about USD 4.5 billion. The acquisition bolstered the company's product portfolio in the point of care testing devices and solutions segment. SoToxa previously referred to as the Alere DDS2 mobile test system, is capable of generating test results indicating the presence of certain drugs in only 5 minutes. SoToxa is presently being utilized by regulation enforcement corporations in countries across the world such as Canada, Germany, Spain, the U.K., and the U.S.
Moreover, In June 2019, Securetec developed the DrugWipe 2S saliva test for buprenorphine and methadone. The two active substances i.e. buprenorphine and methadone were used successfully to treat drug addiction.
Key features of the study:
This proposed research study on the Roadside Drug Testing Devices market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2021-2027), considering 2020 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for the Roadside Drug Testing Devices market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Roadside Drug Testing Devices market
The impact of COVID-19 on Roadside Drug Testing Devices market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on the Roadside Drug Testing Devices market post-COVID will also be covered.
In order to give the users of this report a comprehensive view of the Roadside Drug Testing Devices market, we have also included a competitive landscape and key innovator analysis for the Roadside Drug Testing Devices market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Roadside Drug Testing Devices market.
In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, regional expansion of major participants involved in the market on a global as well as regional level.
The global Roadside Drug Testing Devices market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET KEY PLAYERS
Dragerwerk AG & Co. KGaA
AK GlobalTech Corporation
MAVAND Solutions GmbH
Pacific Data Systems Australia
Cannabix Technologies Inc.
Alcohol Countermeasure Systems Corp.
Lifeloc Technologies, Inc.
GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET, BY MODALITY
GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE
GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE
GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER
Drug Enforcement Agencies
GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of LATAM
The Middle East and Africa
United Arab Emirates
Rest of MEA